-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Prime Medicine, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2021 to Q2 2024.
- Prime Medicine, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $211K, a 92.7% decline year-over-year.
- Prime Medicine, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $5.97M, a 17.7% increase year-over-year.
- Prime Medicine, Inc. annual Nonoperating Income (Expense) for 2023 was $6.38M.
- Prime Medicine, Inc. annual Nonoperating Income (Expense) for 2022 was -$6.23M, a 92.4% increase from 2021.
- Prime Medicine, Inc. annual Nonoperating Income (Expense) for 2021 was -$81.4M, a 13219% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)